PROFILE |
 |
Cepheid develops testing products for genetic profiling, DNA purification, the detection of food and water contaminants, and other applications. The Smart Cycler, its flagship product, is a DNA amplification (rapid duplication) and detection system for life science research. Partners Fischer Scientific, Eurogentec, and Takara Shuzo sell the system in select markets in North America, Europe, and Asia, respectively. Cepheid is also developing GeneXpert, a system designed to extract and examine DNA from blood samples, spores, and bacteria from water samples. Aridia, its joint venture with Canada's Infectio Diagnostic, is developing molecular diagnostic tests for bacterial and fungal infections.
COMPETITION |
 |
Applied Biosystems Group (ABI)
Orchid BioSciences, Inc. (ORCH)
QIAGEN N.V. (QGENF)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 7.10
1-Yr. Sales Growth: 97.4%
Employees: 102
Revenue per employee: $69,607.84
KEY PEOPLE |
 |
Thomas L. Gutshall
CEO
Catherine A. Smith
CFO
CONTACT INFO |
 |
1190 Borregas Ave.
Sunnyvale, CA 94089
US
Phone: 408-541-4191
Fax: 408-541-4192
Online: Web Site
|